Viewing Study NCT05053802


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2025-12-26 @ 2:30 AM
Study NCT ID: NCT05053802
Status: RECRUITING
Last Update Posted: 2021-09-23
First Post: 2021-09-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module